Chemical compounds

Details for Australian Patent Application No. 2006215386 (hide)

Owner AstraZeneca AB

Inventors Wang, Bin; Mohr, Peter; Wang, Tao; Lamb, Michelle; Yu, Dingwei

Agent Davies Collison Cave

Pub. Number AU-B-2006215386

PCT Pub. Number WO2006/087530

Priority 60/653,575 16.02.05 US; 60/742,138 01.12.05 US

Filing date 15 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 11 June 2009

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/087530 Priority application(s): WO2006/087530

11 June 2009 Application Accepted

  Published as AU-B-2006215386

8 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006215393-Egg cooking apparatus

2006215385-Uses of human autism susceptibility gene encoding a kinase